Wells Fargo’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12 | Hold |
2
| – | – | ﹤0.01% | 6430 |
|
|
2025
Q1 | $11 | Hold |
2
| – | – | ﹤0.01% | 6303 |
|
|
2024
Q4 | $10 | Hold |
2
| – | – | ﹤0.01% | 6324 |
|
|
2024
Q3 | $13 | Hold |
2
| – | – | ﹤0.01% | 6229 |
|
|
2024
Q2 | $19 | Sell |
2
-56
| -97% | -$532 | ﹤0.01% | 6150 |
|
|
2024
Q1 | $781 | Buy |
58
+45
| +346% | +$606 | ﹤0.01% | 5812 |
|
|
2023
Q4 | $179 | Sell |
13
-1
| -7% | -$14 | ﹤0.01% | 6194 |
|
|
2023
Q3 | $337 | Hold |
14
| – | – | ﹤0.01% | 6071 |
|
|
2023
Q2 | $441 | Sell |
14
-9
| -39% | -$284 | ﹤0.01% | 6204 |
|
|
2023
Q1 | $536 | Hold |
23
| – | – | ﹤0.01% | 6217 |
|
|
2022
Q4 | $445 | Hold |
23
| – | – | ﹤0.01% | 6090 |
|
|
2022
Q3 | $0 | Hold |
23
| – | – | ﹤0.01% | 7164 |
|
|
2022
Q2 | $0 | Buy |
23
+6
| +35% | – | ﹤0.01% | 7271 |
|
|
2022
Q1 | $0 | Hold |
17
| – | – | ﹤0.01% | 7332 |
|
|
2021
Q4 | $0 | Hold |
17
| – | – | ﹤0.01% | 7315 |
|
|
2021
Q3 | $0 | Sell |
17
-6
| -26% | – | ﹤0.01% | 7228 |
|
|
2021
Q2 | $1K | Hold |
23
| – | – | ﹤0.01% | 6414 |
|
|
2021
Q1 | $1K | Buy |
23
+9
| +64% | +$391 | ﹤0.01% | 6404 |
|
|
2020
Q4 | $0 | Buy |
14
+1
| +8% | – | ﹤0.01% | 6723 |
|
|
2020
Q3 | $0 | Sell |
13
-10
| -43% | – | ﹤0.01% | 6581 |
|
|
2020
Q2 | $0 | Sell |
23
-1,242
| -98% | – | ﹤0.01% | 6482 |
|
|
2020
Q1 | $41K | Buy |
1,265
+1,092
| +631% | +$35.4K | ﹤0.01% | 5179 |
|
|
2019
Q4 | $10K | Sell |
173
-733
| -81% | -$42.4K | ﹤0.01% | 5572 |
|
|
2019
Q3 | $62K | Buy |
906
+323
| +55% | +$22.1K | ﹤0.01% | 5225 |
|
|
2019
Q2 | $75K | Sell |
583
-110
| -16% | -$14.2K | ﹤0.01% | 5165 |
|
|
2019
Q1 | $99K | Buy |
693
+234
| +51% | +$33.4K | ﹤0.01% | 5050 |
|
|
2018
Q4 | $48K | Buy |
+459
| New | +$48K | ﹤0.01% | 5242 |
|